{"name":"Labtec GmbH","slug":"labtec-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sustained Release Morphine Sulfate","genericName":"Sustained Release Morphine Sulfate","slug":"sustained-release-morphine-sulfate","indication":"Moderate to severe chronic pain requiring continuous opioid therapy","status":"marketed"}]}],"pipeline":[{"name":"Sustained Release Morphine Sulfate","genericName":"Sustained Release Morphine Sulfate","slug":"sustained-release-morphine-sulfate","phase":"marketed","mechanism":"Sustained-release morphine sulfate binds to opioid receptors in the central nervous system to provide prolonged pain relief.","indications":["Moderate to severe chronic pain requiring continuous opioid therapy","Cancer pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE05VzNuclZ0S0xzZ05pd2pfeWlmdkhpeDM4RGsteTZpM2ZwZGJzQWRSOWt6VlZKWXk2a0k0UWxKYWJEUFdvT29RVllVazJlUERDbGNReGVBeWtrM3piS0QyQjVneHU4Y0F2MHhpYzln0gFyQVVfeXFMTlpZRmxTSFNkWkJSWm0yZVpyNURfVzFYbUtsLWNOd0p3bjJOMHJ0WktsSExNY2c0ajJXX3dMTjFtUUdSRmpTUEFWUWlzbHJJTXN4ak01S1pHUmI4cEVIR3V0Q29zd0JWeldUY2p4bHhLeV9R?oc=5","date":"2025-04-16","type":"regulatory","source":"koreabiomed.com","summary":"After 5-year delay, CMC Pharmaceutical wins FDA nod for oral schizophrenia drug - koreabiomed.com","headline":"After 5-year delay, CMC Pharmaceutical wins FDA nod for oral schizophrenia drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOYkxLOG4wRUZESzEySGJyRUhDVmp5ejJJNEtJczdBMXU5V1RnWGZvb0hFSzNtdnBFMkNPSE5lczcwZHNSUy1BNzJ6VjkzTWpaLUNHeFNPajlLVTVRcjVhLU5VUnlFdmJJSUZJeWQ2N05nNnh4enhlVnhWWGdTaTdVemRBdTJHTXVORVo4cHd4LXk1SUZKckRQTW05eWJBLW9Wc3FuVUp1VFlTSHpQcGNYZ3U3MWxrV0xzbjVuQjBRaU12aVZ4dllpbG1iaFpRVHo2YWhHTGZ3RnRYNm9LMnNqZTZPY2doM04xVFpNR3RpYWhXZjF6dGlmamRyNUNMQklRekM3ZEFJQ1YtQkV3X21HNw?oc=5","date":"2016-02-24","type":"regulatory","source":"NTB Kommunikasjon","summary":"tesa Labtec Announces Successful Completion of FDA Pre-Approval Inspections of Its R&D and Manufacturing Facilities - NTB Kommunikasjon","headline":"tesa Labtec Announces Successful Completion of FDA Pre-Approval Inspections of Its R&D and Manufacturing Facilities","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}